Seminars in Oncology
Volume 36, Issue 5 , Pages 419-431, October 2009

Melanoma in Pediatric, Adolescent, and Young Adult Patients

  • John M. Kirkwood

      Affiliations

    • Departments of Medicine and Dermatology, University of Pittsburgh School of Medicine, and Melanoma and Skin Cancer Program, University of Pittsburgh Cancer Institute, Pittsburgh, PA
    • Corresponding Author InformationAddress correspondence to John M. Kirkwood, MD, Hillman Cancer Research Pavillion, Melanoma Program, 5117 Centre Ave, Ste L132c, Pittsburgh, PA 15213
  • ,
  • Drazen M. Jukic

      Affiliations

    • Departments of Dermatology and Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA
  • ,
  • Bruce J. Averbook

      Affiliations

    • Departments of Surgery and General Medical Sciences (Oncology), MetroHealth Medical Center/Case Western Reserve University, Cleveland, OH
  • ,
  • Leonard S. Sender

      Affiliations

    • Department of Medicine, University of California, Irvine, and CHOC Children's Hospital, Orange, CA

The family practitioner, pediatrician, and dermatologist all have potential roles in the primary prevention, diagnosis, and treatment of localized thin melanomas. Surgical and medical oncologists are often involved when controversy arises over the nature of the skin lesion or whether sentinel lymph node (SLN) biopsies and adjuvant therapy are to be contemplated. This overview of melanoma will deal with the primary and nodal pathology, surgery, and medical therapy of melanoma in pediatric, adolescent, and young adult patients—and will raise areas of controversy that are only recently being addressed in databases of cases from this age group.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Funded by NIH SPORE in Skin Cancer Grant No. P50 CA121973-02, and supported by the Clinical and Translational Science Institute and the Grant Channell Foundation.

PII: S0093-7754(09)00136-5

doi:10.1053/j.seminoncol.2009.07.001

Seminars in Oncology
Volume 36, Issue 5 , Pages 419-431, October 2009